The interaction of the azetidine thiazole side chain with the active site loop (ASL) 3 drives the evolution of IMP metallo-β-lactamase against tebipenem | ||
| dc.conicet.organizacion | Case Western Reserve University | |
| dc.conicet.organizacion | Veterans Affairs Medical Center | |
| dc.conicet.organizacion | Veterans Affairs Medical Center | |
| dc.conicet.organizacion | Veterans Affairs Medical Center | |
| dc.conicet.organizacion | Hiroshima University | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario | |
| dc.conicet.organizacion | Case Western Reserve University | |
| dc.conicet.organizacion | Veterans Affairs Medical Center | |
| dc.conicet.organizacion | Case Western Reserve University | |
| dc.conicet.organizacion | Veterans Affairs Medical Center | |
| dc.conicet.organizacion | Universidad El Bosque | |
| dc.contributor.author | Ono, Daisuke | |
| dc.contributor.author | Cmolik, Anna | |
| dc.contributor.author | Bethel, Christopher R. | |
| dc.contributor.author | Ishii, Yoshikazu | |
| dc.contributor.author | Drusin, Salvador Iván | |
| dc.contributor.author | Moreno, Diego Martin | |
| dc.contributor.author | Vila, Alejandro Jose | |
| dc.contributor.author | Bonomo, Robert A. | |
| dc.contributor.author | Mojica, Maria F. | |
| dc.date.issued | 2024-08 | |
| dc.description.abstract | Imipenemase (IMP) metallo-β-lactamases (MBLs) hydrolyze almost all available β-lactams including carbapenems and are not inhibited by any commercially available β-lactamase inhibitor. Tebipenem (TP) pivoxil is the first orally available carbapenem and possesses a unique bicyclic azetidine thiazole moiety located at the R2 position. TP has potent in vitro activity against Enterobacterales producing extended-spectrum and/or AmpC β-lactamases. Thus far, the activity of TP against IMP-producing strains is understudied. To address this knowledge gap, we explored the structure activity relationships of IMP MBLs by investigating whether IMP-6, IMP-10, IMP-25, and IMP-78 [MBLs with expanded hydrolytic activity against meropenem (MEM)] would demonstrate enhanced activity against TP. Most of the Escherichia coli DH10B strains expressing IMP-1 variants displayed a ≥twofold MIC difference between TP and MEM, while those expressing VIM or NDM variants demonstrated comparable MICs. Catalytic efficiency (kcat/KM) values for the TP hydrolysis by IMP-1, IMP-6, IMP-10, IMP-25, and IMP-78 were significantly lower than those obtained for MEM. Molecular dynamic simulations reveal that V67F and S262G substitutions (found in IMP-78) reposition active site loop 3, ASL-3, to better accommodate the bicyclic azetidine thiazole side chain, allowing microbiological/catalytic activity to approach that of comparison MBLs used in this study. These findings suggest that modifying the R2 side chain of carbapenems can significantly impact hydrolytic stability. Furthermore, changes in conformational dynamics due to single amino acid substitutions should be used to inform drug design of novel carbapenems. | es |
| dc.description.fil | Fil: Ono, Daisuke. Case Western Reserve University; Estados Unidos. Veterans Affairs Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Cmolik, Anna. Veterans Affairs Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Bethel, Christopher R.. Veterans Affairs Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Ishii, Yoshikazu. Hiroshima University; Japón | |
| dc.description.fil | Fil: Drusin, Salvador Iván. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina | |
| dc.description.fil | Fil: Moreno, Diego Martin. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina | |
| dc.description.fil | Fil: Vila, Alejandro Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario; Argentina | |
| dc.description.fil | Fil: Bonomo, Robert A.. Case Western Reserve University; Estados Unidos. Veterans Affairs Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Mojica, Maria F.. Case Western Reserve University; Estados Unidos. Veterans Affairs Medical Center; Estados Unidos. Universidad El Bosque; | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Ono, Daisuke; Cmolik, Anna; Bethel, Christopher R.; Ishii, Yoshikazu; Drusin, Salvador Iván; et al.; The interaction of the azetidine thiazole side chain with the active site loop (ASL) 3 drives the evolution of IMP metallo-β-lactamase against tebipenem; American Society for Microbiology; Antimicrobial Agents and Chemotherapy; 68; 8; 8-2024; 1-14 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0066-4804 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/266913 | |
| dc.journal.ciudad | Washington D.C. | es |
| dc.journal.number | 8 | es |
| dc.journal.pagination | 1-14 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Antimicrobial Agents and Chemotherapy | es |
| dc.journal.volume | 68 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Society for Microbiology | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://journals.asm.org/doi/10.1128/aac.00687-24 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1128/aac.00687-24 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Tebipenem | es |
| dc.subject | Carbapenemase | es |
| dc.subject | Metallo-beta-lactamase | es |
| dc.subject | IMP | es |
| dc.subject.classification | Enfermedades Infecciosas | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | The interaction of the azetidine thiazole side chain with the active site loop (ASL) 3 drives the evolution of IMP metallo-β-lactamase against tebipenem | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.37f154ab-556c-4ee9-9dff-37467492528e_B.pdf
- Tamaño:
- 4.29 MB
- Formato:
- Adobe Portable Document Format